cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Pulse Biosciences Inc
15 own
22 watching
Current Price
$6.12
$0.17
(2.86%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
227.88M
52-Week High
52-Week High
9.69
52-Week Low
52-Week Low
1.18
Average Volume
Average Volume
0.06M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization227.88M
icon52-Week High9.69
icon52-Week Low1.18
iconAverage Volume0.06M
iconDividend Yield--
iconP/E Ratio--
What does the Pulse Biosciences Inc do?
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
Read More
How much money does Pulse Biosciences Inc make?
News & Events about Pulse Biosciences Inc.
Business Wire
3 months ago
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary nanosecond pulsed field ablation (nsPFA) technology for electrophysiology and the treatment of atrial fibrillation, today announced its technology will be highlighted in a poster presentation at the 28th Annual...
Globe Newswire
6 months ago
NEW YORK, Nov. 19, 2022 (GLOBE NEWSWIRE) -- Natera, Inc. (NASDAQ: NTRA) Lifshitz Law PLLC announces that a class action complaint was filed on behalf of shareholders of Natera alleging that Defendants misrepresented and/or failed to disclose that: (i) the Companys Panorama Non-Invasive Prenatal Test...
PR Newswire
7 months ago
Thinking about buying stock in Oblong, Pulse Biosciences, Inmode, Richardson Electronics, or Delta Air Lines? Thinking about buying stock in Oblong, Pulse Biosciences, Inmode, Richardson Electronics, or Delta Air Lines? PR Newswire NEW YORK, Oct. 13, 2022 NEW YORK, Oct. 13, 2022 /PRNewswire...
Business Wire
8 months ago
Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company developing the CellFX System powered by Nano-Pulse Stimulation (NPS) technology, today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance for its CellFX System, expanding the indication for use...
Business Wire
9 months ago
Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX System powered by Nano-Pulse Stimulation (NPS) technology, today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance of expanded energy settings for use with the family...
Frequently Asked Questions
Frequently Asked Questions
What is Pulse Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Pulse Biosciences Inc shares?
plus_minus_icon
How can I buy Pulse Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Pulse Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Pulse Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Pulse Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Pulse Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Pulse Biosciences Inc?
plus_minus_icon
What percentage is Pulse Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Pulse Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$6.12
$0.17
(2.86%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00